Novo Holdings manages the assets of the Novo Nordisk Foundation, with a mission to generate financial returns that support scientific, humanitarian, and societal grants worldwide. As the main shareholder of Novo Nordisk and Novonesis, the Copenhagen-based firm maintains a diversified portfolio covering equities, bonds, infrastructure, real estate, and private equity, with offices in San Francisco, Boston, Singapore, London, and Shanghai. As of 2024, Novo Holdings managed assets totaling approximately €142 billion ($165 billion), investing broadly from seed to growth stage in life sciences, healthcare, and sustainability sectors. The firm is responsible for impact-focused funds and initiative...
Asset class
Impact theme
Investment geographies
